RO7121932
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7121932, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis [Phase 1]